Evidence map›Paper›PMID 41927510›Full record

SynthesisSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2026

Comparative Efficacy and Safety of Fractional CO

Xiaoyan Xiang, Weilong Shuai, Yunzhu Mu

Abstract readSystematic ReviewComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaoyan XiangDepartment of Dermatology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China.
Weilong ShuaiDepartment of Dermatology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China.
Yunzhu MuDepartment of Dermatology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China.

Funding

Nanchong City School Cooperation Project 22SXQT0137
6 · The paper itself

Abstract

backgroundAcne is a prevalent dermatological disorder that profoundly affects patients' quality of life, frequently resulting in both physical discomfort and psychological distress. Conventional treatments, including topical agents, oral medications, and chemical peels, are primarily designed to alleviate symptoms but may be insufficient in effectively addressing persistent acne scars. Recent innovations in therapeutic technologies, such as microneedling radiofrequency (RF) and fractional carbon dioxide (CO MATERIALS AND

methodsMicroneedling RF operates by generating mechanical microinjuries in conjunction with RF energy, thereby stimulating dermal remodeling and collagen synthesis. In contrast, fractional CO

resultsBoth microneedling RF and fractional CO

conclusionMicroneedling RF and fractional CO

Indexed as

Acne VulgarisCicatrixLasers, GasRadiofrequency TherapyAtrophyCombined Modality TherapyHumansMicroneedle Drug DeliveryNeedlesPercutaneous Collagen InductionTreatment Outcomeacne scarsfractional CO2 laserfractional microneedle radiofrequencygolden microneedle radiofrequency

Identifiers

PMID41927510
PMCPMC13052295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.